(Q30935484)

27 June 2017

Recombinant human antibodies against the reverse transcriptase of human immunodeficiency virus type-1. (English)

1 reference

27 June 2017

1 reference

Alon Herschhorn

1

1 reference

27 June 2017

Arie Admon

series ordinal

2

1 reference

27 June 2017

Amnon Hizi

series ordinal

3

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Biochimica et Biophysica Acta

27 June 2017

1 reference

27 June 2017

1648

1 reference

27 June 2017

1-2

1 reference

27 June 2017

154-163

1 reference

Genetic strategies to inhibit HIV.

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Intracellular antibodies (intrabodies) for gene therapy of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

A novel neutralization epitope on the 'thumb' subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Generation of neutralizing antibody to the reverse transcriptase of human immunodeficiency virus type 1 by immunizing of mice with an infectious vaccinia virus recombinant

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Monoclonal Antibodies Define Linear and Conformational Epitopes of HIV-1polGene Products

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

An immunodominant neutralization epitope on the 'thumb' subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by phage display antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Immunological Characterization Of The Human Immunodeficiency Virus Type 1 Reverse Transcriptase Protein By The Use Of Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

CDR substitutions of a humanized monoclonal antibody (CC49): contributions of individual CDRs to antigen binding and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Antibody phage display technology and its applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Expression and characterization of a recombinant novel reverse transcriptase of a porcine endogenous retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Expression in Escherichia coli of a Moloney murine leukemia virus reverse transcriptase whose structure closely resembles the viral enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Analysis of macromolecular interactions using immobilized ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

HIV reverse transcriptase structure-function relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-9639%2803%2900118-3

7 January 2021

10.1016/S1570-9639(03)00118-3

Identifiers

DOI

1 reference

27 June 2017

1 reference